Navigation Links
Study on toxin that tainted spinach reveals treatment possibility
Date:12/3/2007

BUFFALO, N.Y. -- A discovery by University at Buffalo biologists that may explain the evolution of a lethal toxin is providing new information that could lead to more effective treatments for humans who fall victim to it.

The toxin, known as Shiga toxin, is the same one found last year in bagged spinach that was implicated in the deaths of five people and illnesses involving hundreds more.

The UB research on Shiga Toxin Toxicity and Resistance in Tetrahymena, presented today (Dec. 3, 2007) in Washington, D.C., at the annual meeting of the American Society for Cell Biology, provides the most complete picture to date of the complex biological mechanisms of bacterial viruses infected with this toxin.

Theres a difference between a bacterial virus and a human virus, said Gerald Koudelka, Ph.D., professor and chair in the UB Department of Biological Sciences and a co-author on the study, and its crucial to understanding what kind of infection youre dealing with.

Toxins like Shiga piggyback onto bacterial viruses, using them to become mobile, Koudelka said, while the viruses, in turn, become part of a bacteriums DNA.

A longstanding hypothesis of this field is that toxins may have evolved to do something else besides kill mammals, said Koudelka. Our work is the best evidence yet that thats true.

The distinction between viruses designed to kill mammals and those designed to kill bacteria should turn out to be more than a scientific novelty, Koudelka said.

With the number of bacterial viruses encoding toxins like Shiga outstripping the number of mammals by hundreds of orders of magnitude, researchers have long wondered why they are so prevalent.

To find out, the UB biologists tested the idea that they exist to ward off eukaryotic predators of bacteria like protozoa, such as Tetrahymena.

When the UB team exposed an E. coli strain that did not carry the Shiga-toxin to Tetrahymena (a eukaryote), the bacteria, predictably, were eaten.
'/>"/>

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-5000 x1415
University at Buffalo
Source:Eurekalert

Page: 1 2

Related biology news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Study begins to reveal clues to the cause and progression of sepsis
4. Clones on task serve greater good, evolutionary study shows
5. New study warns limited carbon market puts 20 percent of tropical forest at risk
6. New study examines how rearing environment can alter navigation
7. Study links cat disease to flame retardants in furniture and to pet food
8. New continent and species discovered in Atlantic study
9. Study shows link between alcohol consumption and hiv disease progression
10. Feeling hot, hot, hot: New study suggests ways to control fever-induced seizures
11. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)... PROVO, Utah , Dec. 4, 2014  Tute ... has raised $2.3 million in Series A1 funding led ... angel investors also participated in the investment round. ... as the healthcare community adopts next-generation sequencing and seeks ... disease," said Reid Robison , MD MBA, and ...
(Date:12/3/2014)... 2014   Marvin Test Solutions , a ... for military, aerospace, and manufacturing organizations, today announced ... TS-900 PXI semiconductor test platform . The ... systems to customers at a fraction of the ... ATE. "Our semiconductor customers asked ...
(Date:11/21/2014)... DALLAS , November 18, 2014 ... Security Systems Market by Systems (Video, RFID, Access Control, ... (SEZ, Factories, Hotels, Banks, Government), Component Service Geography - ... Security Systems Market is projected to be around $25 ... Billion by 2020, growing at a CAGR of 8.69%. ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... a new blood protein associated with prostate cancer, researchers ... prostate cancer antigen, can successfully detect prostate cancer in ... successfully avoids the problem of false positive results that ... in the May 15, 2005, issue of Cancer Research. ...
... similar to a drug used in the treatment of Parkinson's ... be used to develop drug therapy for cocaine abuse, new ... 23, 2005, issue of The Journal of Neuroscience, Jonathan Katz ... (NIDA) report the results of experiments showing that mice treated ...
... genetically modified to brandish a powerful "on-switch" that prompts ... finding, from researchers at St. Jude Children's Research Hospital, ... who receive treatment for acute lymphoblastic leukemia (ALL) or ... study are published in the current online issue of ...
Cached Biology News:Test for early detection of prostate cancer shows promise 2Potential Drug Target For Treating Cocaine Abuse Found 2Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells 2
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., ... has filed a Clinical Trial Application (CTA) with the ... Regulatory Agency (MHRA) seeking regulatory approval to initiate clinical ... Anatabine Citrate. Contingent on the Company receiving ... Phase I trial to assess the safety, tolerability and ...
(Date:12/22/2014)... 2014 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... on the development of autologous cell therapies, announced today ... of Calgary in conjunction with co-authors from Kyoto University ... the company,s ongoing clinical research using dermal sheath cup ... The paper entitled " Hair Follicle Dermal ...
(Date:12/22/2014)... December 22, 2014 The ... publication of original research, reviews and editorials addressing ... clinical practice, today published a provocative article exploring ... development, progression and potential treatment of prostate cancer. ... research and proposes the possibility that there could ...
(Date:12/19/2014)... 2014 Charm Sciences is pleased to ... Detection of Aflatoxin M1 in raw commingled milk is ... party validation. The peer reviewed report of the validation ... for Agricultural and Fisheries Research (ILVO-T&V) has been published ... B1, the most toxic aflatoxin and a known carcinogen, ...
Breaking Biology Technology:Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... 11 Amira Pharmaceuticals, Inc., a small molecule pharmaceutical company ... to treat inflammatory disease, announced today that Robert Baltera, Chief ... Annual J.P. Morgan Healthcare Conference. The presentation is scheduled ... Westin St. Francis in San Francisco, Calif. The J.P. ...
... , , , , , ... Expansion of Cooperation With Diabetes Leader Novo Nordisk, ... , The Gerresheimer Group has set up ... is to commence operations early in,2010. On the basis of a ...
... ... of advanced flow measurement, control and level solutions, has launched the redesign of ... about Brooks Instrument’s products, as well as access to Brooks experts who can ... ...
Cached Biology Technology:Amira Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference 2Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil 2Brooks Instrument Unveils New Web site 2
RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
See product name for description....
... Cryo/CryoPlus Inventory Racks for cryogenic ... with cardboard or stainless steel ... 5ml cryo vials. Vapor ... available. Platform risers to ...
Human/Rat Neurogenin-2 MAb (Clone 7G4) Protein Family: Neural Crest Cell Markers, Transcription Factors...
Biology Products: